104 related articles for article (PubMed ID: 30539572)
1. Determination of Autoantibodies to Salivary Gland Antigens.
Cui L; Zhao X; Hu S
Methods Mol Biol; 2019; 1901():103-112. PubMed ID: 30539572
[TBL] [Abstract][Full Text] [Related]
2. Investigation of three potential autoantibodies in Sjogren's syndrome and associated MALT lymphoma.
Cui L; Elzakra N; Xu S; Xiao GG; Yang Y; Hu S
Oncotarget; 2017 May; 8(18):30039-30049. PubMed ID: 28404907
[TBL] [Abstract][Full Text] [Related]
3. FcRL4
Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
[TBL] [Abstract][Full Text] [Related]
4. Analysis of parotid glands of primary Sjögren's syndrome patients using proteomic technology reveals altered autoantigen composition and novel antigenic targets.
Stea EA; Routsias JG; Samiotaki M; Panayotou G; Papalambros E; Moutsopoulos HM; Tzioufas AG
Clin Exp Immunol; 2007 Jan; 147(1):81-9. PubMed ID: 17177966
[TBL] [Abstract][Full Text] [Related]
5. A role for lymphotoxin in primary Sjogren's disease.
Shen L; Suresh L; Wu J; Xuan J; Li H; Zhang C; Pankewycz O; Ambrus JL
J Immunol; 2010 Nov; 185(10):6355-63. PubMed ID: 20952683
[TBL] [Abstract][Full Text] [Related]
6. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
Beckman KA; Luchs J; Milner MS; Ambrus JL
Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
[TBL] [Abstract][Full Text] [Related]
7. The minor salivary gland proteome in Sjögren's syndrome.
Hjelmervik TO; Jonsson R; Bolstad AI
Oral Dis; 2009 Jul; 15(5):342-53. PubMed ID: 19364392
[TBL] [Abstract][Full Text] [Related]
8. Identification of autoantibody biomarkers for primary Sjögren's syndrome using protein microarrays.
Hu S; Vissink A; Arellano M; Roozendaal C; Zhou H; Kallenberg CG; Wong DT
Proteomics; 2011 Apr; 11(8):1499-507. PubMed ID: 21413148
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential saliva and tear biomarkers in primary Sjögren's syndrome, utilising the extraction of extracellular vesicles and proteomics analysis.
Aqrawi LA; Galtung HK; Vestad B; Øvstebø R; Thiede B; Rusthen S; Young A; Guerreiro EM; Utheim TP; Chen X; Utheim ØA; Palm Ø; Jensen JL
Arthritis Res Ther; 2017 Jan; 19(1):14. PubMed ID: 28122643
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against a 72-kDa ductal cell membrane glycoprotein in a patient affected by Sjögren's syndrome and gastric MALT lymphoma.
Folli F; Perego L; Ponzoni M; Girardi AM; Bosi E; Ferreri AJ; Bellone M; Sabbadini MG; Vicari AM; Trusolino L
Ann Hematol; 2002 Oct; 81(10):597-602. PubMed ID: 12424543
[TBL] [Abstract][Full Text] [Related]
11. Thymosin β
Bosello S; Peluso G; Iavarone F; Tolusso B; Messana I; Faa G; Castagnola M; Ferraccioli G
Arthritis Res Ther; 2016 Oct; 18(1):229. PubMed ID: 27716395
[TBL] [Abstract][Full Text] [Related]
12. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.
Fox RI; Kang HI; Ando D; Abrams J; Pisa E
J Immunol; 1994 Jun; 152(11):5532-9. PubMed ID: 8189070
[TBL] [Abstract][Full Text] [Related]
13. Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome.
Guggino G; Ciccia F; Raimondo S; Giardina G; Alessandro R; Dieli F; Sireci G; Triolo G
Clin Exp Rheumatol; 2016; 34(1):25-31. PubMed ID: 26633038
[TBL] [Abstract][Full Text] [Related]
14. The evaluation of disease activity in Sjögren's syndrome based on the degree of MALT involvement: glandular swelling and cryoglobulinaemia compared to ESSDAI in a cohort study.
De Vita S; Gandolfo S; Zandonella Callegher S; Zabotti A; Quartuccio L
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):150-156. PubMed ID: 30156548
[TBL] [Abstract][Full Text] [Related]
15. The Proteomics of Saliva in Sjögren's Syndrome.
Katsiougiannis S; Wong DT
Rheum Dis Clin North Am; 2016 Aug; 42(3):449-56. PubMed ID: 27431347
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome.
Ciccia F; Accardo-Palumbo A; Alessandro R; Alessandri C; Priori R; Guggino G; Raimondo S; Carubbi F; Valesini G; Giacomelli R; Rizzo A; Triolo G
Clin Exp Immunol; 2015 Aug; 181(2):230-8. PubMed ID: 25902739
[TBL] [Abstract][Full Text] [Related]
17. Primary Sjögren's syndrome.
Rischmueller M; Tieu J; Lester S
Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):189-220. PubMed ID: 27421224
[TBL] [Abstract][Full Text] [Related]
18. The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
Jonsson R; Vogelsang P; Volchenkov R; Espinosa A; Wahren-Herlenius M; Appel S
Immunol Lett; 2011 Dec; 141(1):1-9. PubMed ID: 21777618
[TBL] [Abstract][Full Text] [Related]
19. Increase in acrolein-conjugated immunoglobulins in saliva from patients with primary Sjögren's syndrome.
Hirose T; Saiki R; Uemura T; Suzuki T; Dohmae N; Ito S; Takahashi H; Ishii I; Toida T; Kashiwagi K; Igarashi K
Clin Chim Acta; 2015 Oct; 450():184-9. PubMed ID: 26301996
[TBL] [Abstract][Full Text] [Related]
20. Passive transfer of antibodies to the linear epitope 60 kD Ro 273-289 induces features of Sjögren's syndrome in naive mice.
Maier-Moore JS; Kurien BT; D'Souza A; Bockus L; Asfa S; Dorri Y; Hubbell S; Yeliosof O; Obeso D; Schoeb TR; Jonsson R; Scofield RH
Clin Exp Immunol; 2015 Apr; 180(1):19-27. PubMed ID: 25370295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]